Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.67 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.59 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.59 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | MAPT | P10636 | 4/20 | 0.57 |
| ▸ | HPGD | P15428 | 4/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | GMNN | O75496 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | BLM | P54132 | 2/20 | 0.57 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.57 |
| ▸ | CMKLR1 | Q99788 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5843317 | 0.85 | ALDH1A1 (0.63) | PTPN1NR4A1NR4A2NR4A3ALDH1A1 | |
| SCHEMBL29457006 | 0.83 | PTPN1 (0.71) | PTPN1NR4A1NR4A2NR4A3ALDH1A1 | |
| SCHEMBL5857951 | 0.83 | PTPN1 (0.71) | PTPN1NR4A1NR4A2NR4A3ALDH1A1 | |
| SCHEMBL11713079 | 0.82 | PTPN1 (0.69) | PTPN1NR4A1NR4A2NR4A3ALDH1A1 | |
| SCHEMBL30375866 | 0.82 | PTPN1 (0.69) | PTPN1NR4A1NR4A2NR4A3ALDH1A1 | |
| SCHEMBL1448941 | 0.82 | PTPN1 (0.69) | PTPN1NR4A1NR4A2NR4A3ALDH1A1 | |
| SCHEMBL5137793 | 0.81 | PTPN1 (0.62) | PTPN1NR4A1NR4A2NR4A3ALDH1A1 | |
| SCHEMBL13064900 | 0.80 | PTPN1 (0.67) | PTPN1NR4A1NR4A2NR4A3ALDH1A1 | |
| SCHEMBL5130621 | 0.80 | PTPN1 (0.67) | PTPN1NR4A1NR4A2NR4A3ALDH1A1 | |
| SCHEMBL2124452 | 0.80 | PTPN1 (0.67) | PTPN1NR4A1NR4A2NR4A3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1887008-B1 | THIENOTRIAZOLODIAZEPINE COMPOUND AND A MEDICINAL USE THEREOF | MITSUBISHI TANABE PHARMA CORP (JP) | 2021-04-21 | — | — | EP | disclosed |
| US-8802713-B2 | 3-alkoxy-1-phenylpyrazole derivatives and pesticides | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2014-08-12 | — | — | US | disclosed |
| US-20140057334-A1 | AGENT THAT MODULATES PHYSIOLOGICAL CONDITION OF PESTS, INVOLVED IN INSECT CHOLINE ACETYLTRANSFERASE ACTIVITY | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-02-27 | — | — | US | disclosed |
| US-8476035-B2 | Agent that modulates physiological condition of pests, involved in insect choline acetyltransferase activity | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-07-02 | — | — | US | disclosed |
| EP-2202226-B1 | 3-ALKOXY-1-PHENYLPYRAZOLE DERIVATIVE AND PEST CONTROL AGENT | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2013-06-05 | — | — | EP | disclosed |
| US-8044042-B2 | Thienotriazolodiazepine compound and medicinal use thereof | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2011-10-25 | — | — | US | disclosed |
| US-20110028423-A1 | AGENT THAT MODULATES PHYSIOLOGICAL CONDITION OF PESTS, INVOLVED IN INSECT CHOLINE ACETYLTRANSFERASE ACTIVITY | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-02-03 | — | — | US | disclosed |
| US-20100210704-A1 | 3-ALKOXY-1-PHENYLPYRAZOLE DERIVATIVES AND PESTICIDES | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-08-19 | — | — | US | disclosed |
| EP-2202226-A1 | 3-ALKOXY-1-PHENYLPYRAZOLE DERIVATIVE AND PEST CONTROL AGENT | Kumiai Chemical Industry CO., LTD. (JP) | 2010-06-30 | — | — | EP | disclosed |
| US-20100041643-A1 | THIENOTRIAZOLODIAZEPINE COMPOUND AND MEDICINAL USE THEREOF | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2010-02-18 | — | — | US | disclosed |
| US-6790958-B2 | ANTIPROLIFERATIVE AGENTS; FUNGICIDES | LUM ROBERT T (US) | 2004-09-14 | — | — | US | disclosed |
| CN-1161356-C | Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha' | CV���ƹ�˾ | 2004-08-11 | — | — | CN | disclosed |
| EP-1441256-A1 | Radiation-sensitive resin composition | JSR Corporation (JP) | 2004-07-28 | — | — | EP | disclosed |
| US-6727032-B1 | USEFUL IN MICRO-PROCESSING USING VARIOUS RADIATIONS, E.G., FAR-ULTRAVIOLET RADIATION SUCH AS KRF EXCIMER LASER OR ARF EXCIMER LASER, X RAYS SUCH AS SYNCHROTRON RADIATION, CHARGED PARTICLE RADIATION SUCH AS ELECTRON BEAM, ETC. | JSR CORPORATION (JP) | 2004-04-27 | — | — | US | disclosed |
| US-6692887-B1 | COPOLYMER OF SUCH AS MALEIC ANHYDRIDE AND NORBORNENE ACID CLEAVABLE DERIVATIVE; TRANSPARENCY; DRY ETCHING RESISTANCE; PHOTORESIST PATTERN WITH HIGH ADHESION, SENSITIVITY, RESOLUTION AND DEVELOPABILITY | JSR CORPORATION (JP) | 2004-02-17 | — | — | US | disclosed |
| US-6399731-B2 | SYNTHESIZING POLYMERS USING PHOSPHOROUS-CONTAINING ADDITION-FRAGMENTATION CHAIN TRANSFER AGENTS; MOLECULAR WEIGHT CONTROL | THE UNIVERSITY OF AKRON | 2002-06-04 | — | — | US | disclosed |
| US-20020016424-A1 | Synthesizing polymers using phosphorous-containing addition-fragmentation chain transfer agents; molecular weight control | AKRON, THE UNIVERSITY OF | 2002-02-07 | — | — | US | disclosed |
| WO-2000020465-A1 | NOVEL CHAIN TRANSFER AGENTS | THE UNIVERSITY OF AKRON (US) | 2000-04-13 | — | — | WO | disclosed |
| CN-1231611-A | Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha' | CV THERAPEUTIC INC (US) | 1999-10-13 | — | — | CN | disclosed |
| EP-0789278-A2 | Radiation-sensitive resin composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1997-08-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100210704-A1 | 3-ALKOXY-1-PHENYLPYRAZOLE DERIVATIVES AND PESTICIDES | HCN3, HCN4, KCNH3 | PTPN1 1077/4885NR4A1 1576/4885NR4A2 2027/4885 |
| US-20100041643-A1 | THIENOTRIAZOLODIAZEPINE COMPOUND AND MEDICINAL USE THEREOF | ICOS, CD4, CD2 | PTPN1 484/4885NR4A1 1133/4885NR4A2 1035/4885 |
| US-20110028423-A1 | AGENT THAT MODULATES PHYSIOLOGICAL CONDITION OF PESTS, INVOLVED IN INSECT CHOLINE ACETYLTRANSFERASE ACTIVITY | ACHE, CHAT, BCHE | PTPN1 4070/4885NR4A1 4157/4885NR4A2 2591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.